Stay updated on CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Sign up to get notified when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.

Latest updates to the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page
- Check6 days agoChange DetectedThe related topics section no longer lists 'Rheumatoid arthritis' and the related topic 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedRheumatoid arthritis and MedlinePlus Genetics are added as related topics on the study page. These additions provide contextual links rather than core study details.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page shows a new site revision label 'Revision: v3.3.2'. The related topics section no longer includes 'Rheumatoid arthritis', 'MedlinePlus Genetics', or 'Revision: v3.2.0'.SummaryDifference0.3%

- Check28 days agoChange DetectedRemoved the notice about the lapse in government funding and NIH operating status from the page, which does not affect the clinical trial details or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedThe new screenshot shows a redesigned page layout, but core study details like eligibility, interventions, outcomes, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedAdded a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.SummaryDifference7%

Stay in the know with updates to CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 vs China Remicade in Rheumatoid Arthritis Clinical Trial page.